|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03759 PHARMARON
Nominal 
20.880 +2.060 (+10.946%) Ranking Overview
Ranking based on 9 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
9
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 94.43 RMB (cts) | |
| Net Profit | 1,663.90 RMB (MIL) | DPS | 20.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | 2,158.00 | 122.00 | 24.05 | -- | 2,461.00 | 1,900.00 |
| 2027 | 2,654.00 | 150.00 | 28.70 | -- | 3,106.00 | 2,157.00 |
| 2028 | 3,151.00 | 177.50 | 42.30 | -- | 3,775.00 | 2,527.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 2,239.00 | 127.20 | 24.05 | CITIGROUP | Buy | 45.00 | 24/02/2026 | |
| 2026 | 2,105.00 | 118.00 | 16.62 | HUATAI FIN HLDGS HK | Buy | 33.69 | 29/10/2025 | |
| 2026 | 2,461.00 | 138.00 | 35.00 | UBS | Buy | 32.90 | 30/03/2026 | |
| 2026 | 2,072.00 | 117.00 | -- | MORGAN STANLEY | Overweight | 31.00 | 11/03/2026 | |
| 2026 | 2,078.50 | 117.00 | 21.00 | GOLDMAN SACHS | Buy | 30.00 | 29/10/2025 | |
| 2026 | 2,171.00 | 123.00 | 24.57 | CLSA | OutPerform | 28.80 | 11/03/2026 | |
| 2026 | 2,256.00 | 127.00 | 25.00 | HSBC | Buy | 28.10 | 15/10/2025 | |
| 2026 | 2,158.00 | 122.00 | -- | NOMURA | Buy | 27.33 | 31/03/2026 | |
| 2026 | 1,900.00 | 108.00 | 26.10 | BANK OF AMERICA | Buy | 27.00 | 31/03/2026 | |
| 2027 | 2,694.00 | 153.00 | 29.60 | CITIGROUP | -- | -- | 24/02/2026 | |
| 2027 | 2,529.00 | 142.00 | 20.04 | HUATAI FIN HLDGS HK | -- | -- | 29/10/2025 | |
| 2027 | 3,106.00 | 175.00 | 44.00 | UBS | -- | -- | 30/03/2026 | |
| 2027 | 2,824.00 | 159.00 | -- | MORGAN STANLEY | -- | -- | 11/03/2026 | |
| 2027 | 2,391.20 | 135.00 | 25.00 | GOLDMAN SACHS | -- | -- | 29/10/2025 | |
| 2027 | 2,654.00 | 150.00 | 31.13 | CLSA | -- | -- | 11/03/2026 | |
| 2027 | 2,760.00 | 155.00 | 31.00 | HSBC | -- | -- | 15/10/2025 | |
| 2027 | 2,567.00 | 145.00 | -- | NOMURA | -- | -- | 31/03/2026 | |
| 2027 | 2,157.00 | 122.00 | 28.70 | BANK OF AMERICA | -- | -- | 31/03/2026 | |
| 2028 | 3,775.00 | 212.00 | 53.00 | UBS | -- | -- | 30/03/2026 | |
| 2028 | 2,527.00 | 143.00 | 31.60 | BANK OF AMERICA | -- | -- | 31/03/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 01/04/2026 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,663,899 |
| %Change | -7.218% |
| EPS / (LPS) | RMB 0.944 |
| NBV Per Share (¥) | RMB -- |